In the PI3K/AKT signaling pathway, miR-944 targets VEGF in osteosarcoma (SaOS) [39], MACC1 in GC [35], and MDM2 in NPC [7] and CRC [37]. This evidence concerns the gene AKT1 and gastric cancer.